Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

被引：0
|
作者：
Andrew S. Chi
Rohinton S. Tarapore
Matthew D. Hall
Nicole Shonka
Sharon Gardner
Yoshie Umemura
Ashley Sumrall
Ziad Khatib
Sabine Mueller
Cassie Kline
Wafik Zaky
Soumen Khatua
Shiao-Pei Weathers
Yazmin Odia
Toba N. Niazi
Doured Daghistani
Irene Cherrick
David Korones
Matthias A. Karajannis
Xiao-Tang Kong
Jane Minturn
Angela Waanders
Isabel Arillaga-Romany
Tracy Batchelor
Patrick Y. Wen
Krystal Merdinger
Lee Schalop
Martin Stogniew
Joshua E. Allen
Wolfgang Oster
Minesh P. Mehta
机构：
[1] NYU Langone Health and School of Medicine,Radiation Oncology
[2] Oncoceutics,undefined
[3] Miami Cancer Institute,undefined
[4] Nicklaus Children’s Hospital,undefined
[5] University of Nebraska Medical Center,undefined
[6] University of Michigan,undefined
[7] Levine Cancer Institute,undefined
[8] University of California,undefined
[9] San Francisco,undefined
[10] M.D. Anderson Cancer Center,undefined
[11] SUNY Upstate Medical University,undefined
[12] University of Rochester,undefined
[13] Memorial Sloan Kettering Cancer Center,undefined
[14] University of California,undefined
[15] Childrens Hospital of Philadelphia,undefined
[16] Massachusetts General Hospital,undefined
[17] Dana-Farber/Brigham and Women’s Cancer Center,undefined
来源：
Journal of Neuro-Oncology | 2019年 / 145卷
关键词：
Pediatric; Adult; Glioma; DRD2 antagonist; ONC201; H3 K27M; Radiation; Diffuse midline; Diffuse intrinsic pontine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 105
页数：8
相关论文
共 50 条
  • [31] ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA
    Arrillaga-Romany, I.
    Lassman, A.
    McGovern, S. L.
    Mueller, S.
    Nabors, L. B.
    van den Bent, M.
    Vogelbaum, M.
    Allen, J. E.
    Melemed, A. S.
    Tarapore, R.
    Wen, P. Y.
    Cloughsey, T.
    NEURO-ONCOLOGY, 2023, 25
  • [32] ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
    Arrillaga-Romany, Isabel
    Lassman, Andrew
    Mcgovern, Susan L.
    Mueller, Sabine
    Nabors, Burt
    van den Bent, Martin
    Vogelbaum, Michael A.
    Allen, Joshua E.
    Melemed, Allen S.
    Tarapore, Rohinton S.
    Wen, Patrick Y.
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2024, 26 : S173 - S181
  • [33] Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma.
    Kurz, Sylvia Christine
    Tarapore, Rohinton
    Odia, Yazmin
    Butowski, Nicholas A.
    Koschmann, Carl Johannes
    Aguilera, Dolly
    MacDonald, Tobey J.
    Lu, Guangrong
    Allen, Joshua E.
    Oster, Wolfgang
    Mehta, Minesh P.
    Chi, Andrew S.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
    Kawakibi, Abed Rahman
    Tarapore, Rohinton
    Gardner, Sharon
    Chi, Andrew
    Kurz, Sylvia
    Wen, Patrick Y.
    Arrillaga-Romany, Isabel
    Batchelor, Tracy
    Butowski, Nicholas
    Sumrall, Ashley
    Shonka, Nicole
    Harrison, Rebecca
    DeGroot, John
    Mehta, Minesh
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Cloughesy, Timothy
    Ellingson, Benjamin
    Kim, Michelle
    Umemura, Yoshie
    Garton, Hugh
    Franson, Andrea
    Schwartz, Jonathan
    Li, Sunjong
    Cartaxo, Rodrigo
    Ravi, Karthik
    Cantor, Evan
    Cummings, Jessica
    Paul, Alyssa
    Walling, Dustin
    Dun, Matthew
    Cain, Jason
    Li, Jiang
    Filbin, Mariella
    Zhao, Lili
    Kumar-Sinha, Chandan
    Mody, Rajen
    Chinnaiyan, Arul
    Kurokawa, Ryo
    Pratt, Drew
    Venneti, Sriram
    Grill, Jacques
    Kline, Cassie
    Mueller, Sabine
    Resnick, Adam C.
    Nazarian, Javad
    Waszak, Sebastian
    Allen, Joshua E.
    Koschmann, Carl
    NEURO-ONCOLOGY, 2022, 24 : 86 - 87
  • [35] Cerebellar Diffuse Midline Glioma, H3 K27M-Mutant in an Adult Patient: Case Report
    Craig, Zachary
    Malafronte, Patrick
    Johnson, Jeptha
    Theeler, Brett
    NEUROLOGY, 2017, 88
  • [36] LONGITUDINAL MONITORING OF PLASMA H3K27M IN DIFFUSE MIDLINE GLIOMA PATIENTS TREATED WITH ONC201
    Tarapore, Rohinton S.
    Field, Amanda
    Hill, D. Ashley
    Allen, Joshua
    NEURO-ONCOLOGY, 2020, 22 : 11 - 11
  • [37] Diffuse Midline Glioma H3 K27M-Mutant Manifested as Progressive Paraplegia
    Goldstein, Eric D.
    Kyper, Christopher M.
    Siegel, Jason L.
    NEUROHOSPITALIST, 2020, 10 (01): : 73 - 74
  • [38] PHASE 1 STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH H3 K27M-MUTANT HIGH GRADE GLIOMA OR NEWLY DIAGNOSED DIPG
    Gardner, Sharon
    Suarez, Fernando
    Stafford, James M.
    Tarapore, Rohinton S.
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Chi, Andrew S.
    Fuller-Becker, Hope
    Yaffe, Anna
    Allen, Jeffrey C.
    NEURO-ONCOLOGY, 2018, 20 : 201 - 201
  • [39] Diffuse Midline Glioma, H3 K27M-Mutant With Osseous Metastases At Diagnosis
    Fuller, Christine
    Lazow, Margot
    Johnson, Sheryl
    Vadivelu, Sudhakar
    Johnson, Neil
    Koch, Bernadette
    Leach, James
    O'Brien, William
    Breneman, John
    Trout, Andrew
    Fouladi, Maryam
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 669 - 669
  • [40] Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight
    Arrillaga-Romany, Isabel
    Miller, Julie J.
    NEURO-ONCOLOGY, 2024, 26 (06) : 991 - 992
12345